Imagine if we could predict who might struggle with mental health by looking at the patterns passed down from parents to children. It is like having a weather forecast for the brain, combining family history, genetics, and environment to spot risks early. This helps doctors step in with support before a crisis happens, rather than waiting for symptoms to appear.
Healthcare systems currently neglect family history in mental health diagnostics, leading to delayed treatment for offspring. There is a critical lack of tools to predict which children of affected parents are at the highest risk.
The project is building a prediction model using environmental, clinical, behavioral, and biological data, alongside ethical guidelines for clinical implementation.
If you are a software developer dealing with the lack of family-based diagnostic tools — this project developed prediction models that use biological and behavioral data to identify high-risk offspring. This allows for the creation of specialized screening apps for early intervention.
If you are a biotech firm dealing with vague targets for mood and psychosis treatments — this project developed molecular mapping and epigenetic insights that reveal new biological targets. This can accelerate the development of preventive therapies to break the cycle of mental illness.
If you are a clinic owner dealing with delayed diagnoses in young patients — this project developed family-based risk prediction tools and ethical guidelines. This enables a shift toward a family-centered care model that improves patient outcomes through early detection.
Based on available project data, no pricing or cost information is provided as the project is currently in the research and development phase.
The project utilizes large human genetic and neuroimaging datasets across 11 countries, suggesting the underlying data models are designed for broad population scale.
Based on available project data, specific IP or licensing terms are not listed; however, the project aims to deliver tools and ethical guidelines for clinical implementation.
The project aims to provide tools and guidelines to help healthcare professionals move toward a family-based approach in diagnostics and care.
The project period runs from 2022-10-01 to 2027-09-30, indicating that final tools and guidelines will be refined toward the end of 2027.
The consortium is heavily research-oriented, consisting of 8 universities and 5 research institutions, with a low industry presence (1 company, 6% ratio). This indicates the project is currently driven by academic discovery and high-level data analysis rather than immediate commercialization. However, the involvement of 11 countries and 18 partners suggests a high level of data diversity and international validation for the resulting models.
Contact Erasmus Universitaire Medisch Centrum Rotterdam
Contact us to explore licensing opportunities for the emerging risk prediction models.
